
HEXO Corp. HEXO
Annual report 2022
added 12-23-2023
HEXO Corp. Operating Cycle 2011-2026 | HEXO
Annual Operating Cycle HEXO Corp.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 775 | 451 | - | - | - | - | - |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 775 | 451 | 613 |
Operating Cycle of other stocks in the Drug manufacturers industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AcelRx Pharmaceuticals
ACRX
|
16.5 | - | 7.5 % | $ 6.35 M | ||
|
Agile Therapeutics
AGRX
|
146 | - | 10.11 % | $ 58.2 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
121 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
576 | - | - | $ 754 M | ||
|
Catalent
CTLT
|
152 | - | - | $ 11.5 B | ||
|
Eagle Pharmaceuticals
EGRX
|
214 | - | -39.89 % | $ 27.7 M | ||
|
Endo International plc
ENDP
|
180 | - | - | $ 28.9 M | ||
|
DURECT Corporation
DRRX
|
560 | - | - | $ 50.1 M | ||
|
Alimera Sciences
ALIM
|
181 | - | - | $ 142 M | ||
|
Athenex
ATNX
|
247 | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
416 | - | - | $ 2.06 B | ||
|
Evoke Pharma
EVOK
|
45.7 | - | - | $ 36.6 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
614 | $ 3.18 | 1.92 % | $ 44.7 M | ||
|
Cronos Group
CRON
|
425 | $ 2.57 | - | $ 1.33 B | ||
|
Bausch Health Companies
BHC
|
78.9 | $ 5.68 | -0.7 % | $ 2.07 B | ||
|
Harrow Health
HROW
|
217 | $ 37.94 | 2.27 % | $ 1.39 B | ||
|
Aurora Cannabis
ACB
|
1.45 K | $ 3.53 | 1.44 % | $ 86.3 M | ||
|
Canopy Growth Corporation
CGC
|
230 | $ 1.09 | 0.93 % | $ 117 M | ||
|
Jupiter Wellness
JUPW
|
112 | - | - | $ 33.6 M | ||
|
OrganiGram Holdings
OGI
|
2.92 K | $ 1.43 | 0.7 % | $ 402 M | ||
|
Lannett Company
LCI
|
210 | - | 1.15 % | $ 7.11 M | ||
|
Evolus
EOLS
|
134 | $ 4.44 | 2.54 % | $ 286 M | ||
|
Emergent BioSolutions
EBS
|
237 | $ 8.66 | 5.1 % | $ 443 M | ||
|
Tilray
TLRY
|
222 | $ 6.91 | 2.83 % | $ 4.27 B | ||
|
Organogenesis Holdings
ORGO
|
159 | $ 2.51 | 5.46 % | $ 330 M | ||
|
Pacira BioSciences
PCRX
|
246 | $ 23.75 | -1.29 % | $ 1.1 B | ||
|
Veru
VERU
|
271 | $ 2.42 | 1.68 % | $ 326 M | ||
|
PetIQ
PETQ
|
108 | - | 1.64 % | $ 400 M | ||
|
Viatris
VTRS
|
219 | $ 13.91 | 0.58 % | $ 16.7 B | ||
|
ProPhase Labs
PRPH
|
141 | - | - | $ 5.07 M | ||
|
cbdMD
YCBD
|
176 | $ 0.73 | -2.28 % | $ 3.15 M | ||
|
Assertio Holdings
ASRT
|
590 | $ 18.02 | - | $ 115 M | ||
|
Radius Health
RDUS
|
220 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
112 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
508 | - | - | $ 1.08 B | ||
|
SCYNEXIS
SCYX
|
106 | $ 1.02 | 0.99 % | $ 50.9 M | ||
|
PLx Pharma
PLXP
|
111 | - | -27.8 % | $ 2.56 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
182 | $ 2.18 | -7.23 % | $ 2.71 M | ||
|
Zomedica Corp.
ZOM
|
218 | - | -0.21 % | $ 98 M | ||
|
Rockwell Medical
RMTI
|
72.5 | $ 0.93 | -1.38 % | $ 33.5 M | ||
|
China Pharma Holdings
CPHI
|
187 | $ 0.63 | -3.05 % | $ 2.7 M | ||
|
TherapeuticsMD
TXMD
|
3.34 K | $ 2.11 | 2.93 % | $ 24.4 M |